{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:46:01Z","timestamp":1784774761608,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ministerie van Volksgezondheid, Welzijn en Sport,The Netherlands"},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["806776"],"award-info":[{"award-number":["806776"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["806776"],"award-info":[{"award-number":["806776"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["806776"],"award-info":[{"award-number":["806776"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["806776"],"award-info":[{"award-number":["806776"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["806776"],"award-info":[{"award-number":["806776"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["806776"],"award-info":[{"award-number":["806776"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["806776"],"award-info":[{"award-number":["806776"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immun Ageing"],"DOI":"10.1186\/s12979-025-00504-0","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T02:25:40Z","timestamp":1741400740000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["CD31 + na\u00efve T cells associate with immunosenescence and responsiveness to multiple vaccines in older adults"],"prefix":"10.1186","volume":"22","author":[{"given":"Alper","family":"Cevirgel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elske","family":"Bijvank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josine","family":"van Beek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"van der Heiden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Buisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"van Baarle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,8]]},"reference":[{"key":"504_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01451-2","author":"Z Liu","year":"2023","unstructured":"Liu Z, et al. Immunosenescence: molecular mechanisms and diseases. Signal Transduct Target Therapy. 2023. https:\/\/doi.org\/10.1038\/s41392-023-01451-2.","journal-title":"Signal Transduct Target Therapy"},{"key":"504_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.exger.2017.10.024","volume":"105","author":"G Pawelec","year":"2017","unstructured":"Pawelec G. Age and immunity: what is Immunosenescence?? Exp Gerontol. 2017;105:4\u20139.","journal-title":"Exp Gerontol"},{"key":"504_CR3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41590-021-00927-z","volume":"22","author":"M Mar\u0131\u0301a","year":"2021","unstructured":"Mar\u0131\u0301a M. Guido Kroemer. Hallmarks of T cell aging. Nat Immunol. 2021;22:687\u201398.","journal-title":"Nat Immunol"},{"key":"504_CR4","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41577-019-0180-1","volume":"19","author":"JJ Goronzy","year":"2019","unstructured":"Goronzy JJ, Weyand CM. Mechanisms underlying T cell ageing. Nat Rev Immunol. 2019;19:573\u201383.","journal-title":"Nat Rev Immunol"},{"key":"504_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13703","author":"A Cevirgel","year":"2022","unstructured":"Cevirgel A, et al. Identification of aging-associated immunotypes and immune stability as indicators of post-vaccination immune activation. Aging Cell. 2022. https:\/\/doi.org\/10.1111\/acel.13703.","journal-title":"Aging Cell"},{"key":"504_CR6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-018-0001-y","volume":"18","author":"T Broek","year":"2018","unstructured":"Broek T, van den, et al. The full spectrum of human Naive T cells. Nat Rev Immunol. 2018;18:363\u201373.","journal-title":"Nat Rev Immunol"},{"key":"504_CR7","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.jaci.2020.03.017","volume":"145","author":"CE Gustafson","year":"2020","unstructured":"Gustafson CE, et al. Influence of immune aging on vaccine responses. J Allergy Clin Immunol. 2020;145:1309\u201321.","journal-title":"J Allergy Clin Immunol"},{"key":"504_CR8","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41577-024-01030-8","volume":"24","author":"TR Mosmann","year":"2024","unstructured":"Mosmann TR, McMichael AJ, LeVert A, McCauley JW, Almond JW. Opportunities and challenges for T cell-based influenza vaccines. Nat Rev Immunol. 2024;24:736\u201352.","journal-title":"Nat Rev Immunol"},{"key":"504_CR9","doi-asserted-by":"publisher","first-page":"2287118","DOI":"10.1080\/22221751.2023.2287118","volume":"13","author":"Y Yang","year":"2024","unstructured":"Yang Y, et al. The characterization of CD8 + T-cell responses in COVID-19. Emerg Microbes Infections. 2024;13:2287118.","journal-title":"Emerg Microbes Infections"},{"key":"504_CR10","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1016\/j.immuni.2024.10.003","volume":"57","author":"J Davis-Porada","year":"2024","unstructured":"Davis-Porada J, et al. Maintenance and functional regulation of immune memory to COVID-19 vaccines in tissues. Immunity. 2024;57:2895\u2013e29138.","journal-title":"Immunity"},{"key":"504_CR11","doi-asserted-by":"publisher","unstructured":"Cevirgel A, et al. Pre-vaccination immunotypes reveal weak and robust antibody responders to influenza vaccination. Aging Cell. 2023;e14048. https:\/\/doi.org\/10.1111\/acel.14048.","DOI":"10.1111\/acel.14048"},{"key":"504_CR12","doi-asserted-by":"publisher","DOI":"10.1101\/2024.05.29.24308098","author":"A Cevirgel","year":"2024","unstructured":"Cevirgel A, et al. Baseline immunotypes and immune entropy are indicators of multiple vaccine responsiveness. MedRxiv. 2024. https:\/\/doi.org\/10.1101\/2024.05.29.24308098.","journal-title":"MedRxiv"},{"key":"504_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50760-9","author":"M van der Heiden","year":"2024","unstructured":"van der Heiden M, et al. Multiple vaccine comparison in the same adults reveals vaccine-specific and age-related humoral response patterns: an open phase IV trial. Nat Commun. 2024. https:\/\/doi.org\/10.1038\/s41467-024-50760-9.","journal-title":"Nat Commun"},{"key":"504_CR14","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1242\/jcs.124099","volume":"126","author":"FM Marelli-Berg","year":"2013","unstructured":"Marelli-Berg FM, Clement M, Mauro C, Caligiuri G. An immunologist\u2019s guide to CD31 function in T-cells. J Cell Sci. 2013;126:2343\u201352.","journal-title":"J Cell Sci"},{"key":"504_CR15","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1182\/blood-2008-02-139154","volume":"113","author":"K\u00f6hler Siegfried","year":"2009","unstructured":"Siegfried K\u00f6hler. Andreas Thiel. Life after the thymus: CD31 + and CD31\u2013 human Naive CD4 + T-cell subsets. Blood. 2009;113:769\u201374.","journal-title":"Blood"},{"key":"504_CR16","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nri2785","volume":"10","author":"S Sakaguchi","year":"2010","unstructured":"Sakaguchi S, et al. FOXP3 + regulatory T cells in the human immune system. Nat Rev Immunol. 2010;10:490\u2013500.","journal-title":"Nat Rev Immunol"},{"key":"504_CR17","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1084\/jem.188.2.287","volume":"188","author":"AM Thornton","year":"1998","unstructured":"Thornton AM, Shevach EM. CD4 + CD25 + Immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med. 1998;188:287\u201396.","journal-title":"J Exp Med"},{"key":"504_CR18","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1182\/blood-2002-07-2103","volume":"101","author":"JM Brenchley","year":"2003","unstructured":"Brenchley JM, et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8 + T cells. Blood. 2003;101:2711\u201320.","journal-title":"Blood"},{"key":"504_CR19","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/eji.201948362","volume":"50","author":"L Pangrazzi","year":"2020","unstructured":"Pangrazzi L, et al. CD28 and CD57 define four populations with distinct phenotypic properties within human CD8 + T cells. Eur J Immunol. 2020;50:363\u201379.","journal-title":"Eur J Immunol"},{"key":"504_CR20","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.1182\/blood-2009-01-199588","volume":"113","author":"SM Henson","year":"2009","unstructured":"Henson SM, et al. KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8 + T cells. Blood. 2009;113:6619\u201328.","journal-title":"Blood"},{"key":"504_CR21","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.3389\/fimmu.2018.02788","volume":"9","author":"A Machicote","year":"2018","unstructured":"Machicote A, Bel\u00e9n S, Baz P, Billordo LA, Fainboim L. Human CD8 + HLA-DR + Regulatory T cells, similarly to classical CD4 + Foxp3 + cells, suppress immune responses via PD-1\/PD-L1 Axis. Front Immunol. 2018;9:2788\u20132788.","journal-title":"Front Immunol"},{"key":"504_CR22","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3389\/fimmu.2018.01201","volume":"9","author":"SL Yani","year":"2018","unstructured":"Yani SL, et al. CD8 + HLADR + Regulatory T cells change with aging: they increase in number, but lose checkpoint inhibitory molecules and suppressive function. Front Immunol. 2018;9:1201\u20131201.","journal-title":"Front Immunol"},{"key":"504_CR23","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1002\/eji.201343751","volume":"43","author":"YD Mahnke","year":"2013","unstructured":"Mahnke YD, et al. The who\u2019s who of T-cell differentiation: human memory T-cell subsets. Eur J Immunol. 2013;43:2797\u2013809.","journal-title":"Eur J Immunol"},{"key":"504_CR24","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/j.1365-2249.2008.03785.x","volume":"155","author":"SM Chidrawar","year":"2009","unstructured":"Chidrawar SM, et al. Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals. Clin Exp Immunol. 2009;155:423\u201332.","journal-title":"Clin Exp Immunol"},{"key":"504_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-37502-5","author":"M Hofstee","year":"2023","unstructured":"Hofstee M, et al. Cytomegalovirus and Epstein\u2013Barr virus co-infected young and middle-aged adults can have an aging-related T-cell phenotype. Sci Rep. 2023. https:\/\/doi.org\/10.1038\/s41598-023-37502-5.","journal-title":"Sci Rep"},{"key":"504_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.exger.2016.02.005","volume":"77","author":"M Weltevrede","year":"2016","unstructured":"Weltevrede M, et al. Cytomegalovirus persistence and T-cell Immunosenescence in people aged Fifty and older: A systematic review. Exp Gerontol. 2016;77:87\u201395.","journal-title":"Exp Gerontol"},{"key":"504_CR27","doi-asserted-by":"crossref","unstructured":"Braber I, den et al. Maintenance of peripheral Naive T cells is sustained by Thymus output in mice but not humans. Immunity. 2012;36.","DOI":"10.1016\/j.immuni.2012.02.006"},{"key":"504_CR28","doi-asserted-by":"crossref","unstructured":"Ghosh A et al. CD38: an ecto-enzyme with functional diversity in T cells. Front Immunol. 2023;14.","DOI":"10.3389\/fimmu.2023.1146791"},{"key":"504_CR29","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/tri.12032","volume":"26","author":"M Schaier","year":"2013","unstructured":"Schaier M, et al. The extent of HLA-DR expression on HLA\u2010DR + Tregs allows the identification of patients with clinically relevant borderline rejection. Transpl Int. 2013;26:290\u20139.","journal-title":"Transpl Int"},{"key":"504_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2020.07.004","author":"AV Churov","year":"2020","unstructured":"Churov AV, Mamashov KY, Novitskaia AV. Homeostasis and the functional roles of CD4 + Treg cells in aging. Immunol Lett. 2020. https:\/\/doi.org\/10.1016\/j.imlet.2020.07.004.","journal-title":"Immunol Lett"},{"key":"504_CR31","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41467-018-03243-7","volume":"9","author":"Z Wang","year":"2018","unstructured":"Wang Z, et al. Clonally diverse CD38 + HLA-DR + CD8 + T cells persist during fatal H7N9 disease. Nat Commun. 2018;9:824\u2013824.","journal-title":"Nat Commun"},{"key":"504_CR32","doi-asserted-by":"publisher","first-page":"735125","DOI":"10.3389\/fimmu.2021.735125","volume":"12","author":"J Du","year":"2021","unstructured":"Du J, et al. Persistent high percentage of HLA-DR + CD38 high CD8 + T cells associated with immune disorder and disease severity of COVID-19. Front Immunol. 2021;12:735125\u2013735125.","journal-title":"Front Immunol"},{"key":"504_CR33","doi-asserted-by":"publisher","first-page":"8329","DOI":"10.1182\/blood-2022-170987","volume":"140","author":"TH Nguyen","year":"2022","unstructured":"Nguyen TH, et al. HLA-DR + CD38high expression in T cells is excellent in quantifying the amplitude of T-Cell activation in a spectrum of hyperinflammatory disorders including HLH. Blood. 2022;140:8329\u201330.","journal-title":"Blood"},{"key":"504_CR34","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1146\/annurev.immunol.18.1.975","volume":"18","author":"Adrian Hayday","year":"2000","unstructured":"Adrian Hayday. [gamma][delta] cells: a right time and a right place for a conserved third way of protection. Annu Rev Immunol. 2000;18:975\u20131026.","journal-title":"Annu Rev Immunol"},{"key":"504_CR35","doi-asserted-by":"publisher","first-page":"8903","DOI":"10.3390\/ijms21238903","volume":"21","author":"BL Clark","year":"2020","unstructured":"Clark BL, Thomas PG. A cell for the ages: human \u0393\u03b4 T cells across the lifespan. Int J Mol Sci. 2020;21:8903.","journal-title":"Int J Mol Sci"},{"key":"504_CR36","doi-asserted-by":"crossref","unstructured":"Dantzler KW et al. Emerging role of \u0393\u03b4 T cells in vaccine-mediated protection from infectious diseases. Clin Translational Immunol. 2019;8.","DOI":"10.1002\/cti2.1072"},{"key":"504_CR37","doi-asserted-by":"publisher","first-page":"311","DOI":"10.4049\/jimmunol.1800934","volume":"203","author":"Adrian Hayday","year":"2019","unstructured":"Adrian Hayday. \u03b3\u03b4 T cell update: adaptate orchestrators of immune surveillance. J Immunol. 2019;203:311\u201320.","journal-title":"J Immunol"},{"key":"504_CR38","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.intimp.2013.01.022","volume":"16","author":"D Kabelitz","year":"2013","unstructured":"Kabelitz D, Peters C, Wesch D, Oberg H-H. Regulatory functions of \u0393\u03b4 T cells. Int Immunopharmacol. 2013;16:382\u20137.","journal-title":"Int Immunopharmacol"},{"key":"504_CR39","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1007\/s00018-013-1467-1","volume":"71","author":"CJ Peters","year":"2014","unstructured":"Peters CJ, et al. Phenotype and regulation of immunosuppressive V\u03b42-expressing \u0393\u03b4 T cells. Cell Mol Life Sci. 2014;71:1943\u201360.","journal-title":"Cell Mol Life Sci"},{"key":"504_CR40","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1615\/CritRevImmunol.v23.i56.10","volume":"23","author":"K Dieter","year":"2003","unstructured":"Dieter K. Daniela Wesch. Features and functions of gamma delta T lymphocytes: focus on chemokines and their receptors. Crit Rev Immunol. 2003;23:339\u201370.","journal-title":"Crit Rev Immunol"},{"key":"504_CR41","doi-asserted-by":"publisher","first-page":"9286","DOI":"10.3390\/ijms21239286","volume":"21","author":"LD Munoz","year":"2020","unstructured":"Munoz LD, Sweeney MJ, Jameson JM. Skin resident \u0393\u03b4 T cell function and regulation in wound repair. Int J Mol Sci. 2020;21:9286.","journal-title":"Int J Mol Sci"},{"key":"504_CR42","doi-asserted-by":"publisher","first-page":"109871","DOI":"10.1016\/j.celrep.2021.109871","volume":"37","author":"V Cazzetta","year":"2021","unstructured":"Cazzetta V, et al. NKG2A expression identifies a subset of human V\u03b42 T cells exerting the highest antitumor effector functions. Cell Rep. 2021;37:109871.","journal-title":"Cell Rep"},{"key":"504_CR43","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ebiom.2018.11.053","volume":"39","author":"W Xu","year":"2019","unstructured":"Xu W, et al. Mapping of \u0393\/\u03b4 T cells reveals V\u03b42 + T cells resistance to senescence. EBioMedicine. 2019;39:44\u201358.","journal-title":"EBioMedicine"},{"key":"504_CR44","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00262-016-1803-z","volume":"65","author":"H Kared","year":"2016","unstructured":"Kared H, et al. CD57 in human natural killer cells and T-lymphocytes. Cancer Immunol Immunother. 2016;65:441\u201352.","journal-title":"Cancer Immunol Immunother"},{"key":"504_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.24501","author":"A Emmaneel","year":"2021","unstructured":"Emmaneel A, et al. PeacoQC: Peak-based selection of high quality cytometry data. Cytometry Part A. 2021. https:\/\/doi.org\/10.1002\/cyto.a.24501.","journal-title":"Cytometry Part A"},{"key":"504_CR46","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/cyto.a.22625","volume":"87","author":"S van Gassen","year":"2015","unstructured":"van Gassen S, et al. FlowSOM: using self-organizing maps for visualization and interpretation of cytometry data. Cytometry Part A. 2015;87:636\u201345.","journal-title":"Cytometry Part A"},{"key":"504_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jim.2018.07.003","volume":"462","author":"I Tcherniaeva","year":"2018","unstructured":"Tcherniaeva I, Hartog Gden, Berbers GAM, van der Klis F. R. M. The development of a bead-based multiplex immunoassay for the detection of IgG antibodies to CMV and EBV. J Immunol Methods. 2018;462:1\u20138.","journal-title":"J Immunol Methods"},{"key":"504_CR48","doi-asserted-by":"crossref","unstructured":"Samson LD et al. Limited effect of duration of CMV infection on adaptive immunity and frailty: insights from a 27-year-long longitudinal study. Clin Translational Immunol. 2020;9.","DOI":"10.1002\/cti2.1193"}],"container-title":["Immunity & Ageing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12979-025-00504-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12979-025-00504-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12979-025-00504-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T14:23:28Z","timestamp":1741443808000},"score":1,"resource":{"primary":{"URL":"https:\/\/immunityageing.biomedcentral.com\/articles\/10.1186\/s12979-025-00504-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,8]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["504"],"URL":"https:\/\/doi.org\/10.1186\/s12979-025-00504-0","relation":{},"ISSN":["1742-4933"],"issn-type":[{"value":"1742-4933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,8]]},"assertion":[{"value":"27 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the study was granted by the Medical Research Ethics Committee Utrecht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants provided written informed consent, and all procedures were conducted in accordance with Good Clinical Practice and the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}